{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:55Z","timestamp":1786997935783,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Basic Science Research Program"},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea Health Technology R&D Project"},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health & Welfare, Republic of Korea","award":["HI16C1032"],"award-info":[{"award-number":["HI16C1032"]}]},{"name":"Ministry of Science, ICT & Future Planning","award":["NRF-2016M3A9B6918676"],"award-info":[{"award-number":["NRF-2016M3A9B6918676"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.vaccine.2018.11.064","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T11:20:27Z","timestamp":1543317627000},"page":"484-493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Preclinical evaluation of the efficacy of an H5N8 vaccine candidate (IDCDC-RG43A) in mouse and ferret models for pandemic preparedness"],"prefix":"10.1016","volume":"37","author":[{"given":"Ju Hwan","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Ha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khristine Kaith S.","family":"Lloren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Jung","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeok-il","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Jeong","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Suk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Jae","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ok-Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Jung","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Hee","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6073-0783","authenticated-orcid":false,"given":"Min-Suk","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ki","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.11.064_b0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/irv.12324","article-title":"Nomenclature updates resulting from the evolution of avian influenza A (H5) virus clades 2.1.3.2a, 2.2.1, and 2.3.4 during 2013\u20132014","volume":"9","author":"Smith","year":"2015","journal-title":"Influenza Other Respir"},{"key":"10.1016\/j.vaccine.2018.11.064_b0010","unstructured":"World Health Organization. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness; 2017."},{"key":"10.1016\/j.vaccine.2018.11.064_b0015","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1128\/JVI.73.2.1146-1155.1999","article-title":"The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties","volume":"73","author":"Matrosovich","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.11.064_b0020","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00405-17","article-title":"Clade 2.3.4.4 A\/H5N6 influenza virus lacks mammalian adaptation markers and does not transmit via the airborne route between ferrets","volume":"3","author":"Herfst","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.vaccine.2018.11.064_b0025","unstructured":"World Health Organization. Evolution of the influenza A(H5) haemagglutinin: WHO\/OIE\/FAO H5 Working Group reports a new clade designated 2.3.4.4; 2015."},{"key":"10.1016\/j.vaccine.2018.11.064_b0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/1348-0421.12478","article-title":"Antigenic diversity of H5 highly pathogenic avian influenza viruses of clade 2.3.4.4 isolated in Asia","volume":"61","author":"Ohkawara","year":"2017","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2018.11.064_b0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4142\/jvs.2017.18.S1.269","article-title":"Evolution global spread, and pathogenicity of highly pathogenic avian influenza H5Nx clade 2.3.4.4","volume":"18","author":"Lee","year":"2017","journal-title":"J Vet Sci"},{"key":"10.1016\/j.vaccine.2018.11.064_b0040","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.apjtb.2015.03.001","article-title":"H5N6 influenza virus infection, the newest influenza","volume":"5","author":"Joob","year":"2015","journal-title":"Asian Pac J Tropical Biomed"},{"key":"10.1016\/j.vaccine.2018.11.064_b0045","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jinf.2015.06.009","article-title":"Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings","volume":"72","author":"Pan","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2018.11.064_b0050","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1038\/emi.2017.38","article-title":"Human infections with novel reassortant H5N6 avian influenza viruses in China","volume":"6","author":"Zhang","year":"2017","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2018.11.064_b0055","unstructured":"World Health Organization. Safety of pandemic vaccines; 2009."},{"key":"10.1016\/j.vaccine.2018.11.064_b0060","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/pathogens3040845","article-title":"Animal models for influenza viruses: implications for universal vaccine development","volume":"3","author":"Margine","year":"2014","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2018.11.064_b0065","unstructured":"(CDC) CfDCaP. Novel Eurasian highly pathogenic avian influenza A H5 viruses in wild birds, Washington, USA, 2014; 2015."},{"key":"10.1016\/j.vaccine.2018.11.064_b0070","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2018.11.064_b0075","doi-asserted-by":"crossref","first-page":"40667","DOI":"10.1038\/srep40667","article-title":"Rapid acquisition of polymorphic virulence markers during adaptation of highly pathogenic avian influenza H5N8 virus in the mouse","volume":"7","author":"Choi","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2018.11.064_b0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1084\/jem.75.1.49","article-title":"The quantitative determination of influenza virus and antibodies by means of red cell agglutination","volume":"75","author":"Hirst","year":"1942","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2018.11.064_b0085","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CVI.00613-15","article-title":"Standardization of hemagglutination inhibition assay for influenza serology allows for high reproducibility between laboratories","volume":"23","author":"Zacour","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.11.064_b0090","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","article-title":"Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays","volume":"37","author":"Rowe","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.11.064_b0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.antiviral.2014.03.002","article-title":"Monovalent H5 vaccine based on epitope-chimeric HA provides broad cross-clade protection against variant H5N1 viruses in mice","volume":"105","author":"He","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2018.11.064_b0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/600035","article-title":"Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues","volume":"49","author":"Uyeki","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.064_b0105","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.chom.2016.10.022","article-title":"Genesis, evolution and prevalence of H5N6 avian influenza viruses in China","volume":"20","author":"Bi","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2018.11.064_b0110","first-page":"261","article-title":"Writing committee of the second world health organization consultation on clinical aspects of human infection with avian influenza A (H5N1) virus. Update on avian influenza A (H5N1) virus infection in humans","volume":"358","author":"Abdel-Ghafar","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.11.064_b0115","doi-asserted-by":"crossref","first-page":"792","DOI":"10.4161\/hv.6.10.12915","article-title":"Pre-pandemic and pandemic influenza vaccines","volume":"6","author":"Rockman","year":"2010","journal-title":"Hum Vaccines"},{"key":"10.1016\/j.vaccine.2018.11.064_b0120","doi-asserted-by":"crossref","first-page":"11822","DOI":"10.1128\/JVI.00891-10","article-title":"Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages","volume":"84","author":"Prabakaran","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.11.064_b0125","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1128\/CVI.00662-14","article-title":"Long-term immunogenicity of an inactivated split-virion 2009 pandemic influenza A H1N1 virus vaccine with or without aluminum adjuvant in mice","volume":"22","author":"Xu","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.11.064_b0130","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1128\/CVI.00174-07","article-title":"Development and evaluation of an Influenza virus subtype H7N2 vaccine candidate for pandemic preparedness","volume":"14","author":"Pappas","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.11.064_b0135","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12275-012-1573-z","article-title":"Evaluation of the efficacy of a pre-pandemic H5N1 vaccine (MG1109) in mouse and ferret models","volume":"50","author":"Song","year":"2012","journal-title":"J Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T22:08:05Z","timestamp":1605478085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18315895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0264410X18315895"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.064","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical evaluation of the efficacy of an H5N8 vaccine candidate (IDCDC-RG43A) in mouse and ferret models for pandemic preparedness","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}